A non-randomised single centre cohort study, comparing standard and modified bowel preparations, in adults with cystic fibrosis requiring colonoscopy
- PMID: 31195989
- PMCID: PMC6567575
- DOI: 10.1186/s12876-019-0979-z
A non-randomised single centre cohort study, comparing standard and modified bowel preparations, in adults with cystic fibrosis requiring colonoscopy
Abstract
Background: Adults with cystic fibrosis (CF) have been reported to be at five to ten-fold risk (25 to 30 fold risk after solid organ transplant) of colorectal cancer (CRC) than the general population. Limited publications to date have reported on practical aspects of achieving adequate colonic cleanse producing good visualisation. In this study, we compared two bowel preparation regimens, standard bowel preparation and a modified CF bowel preparation.
Methods: A non-randomised study of adults with CF attending a single centre, requiring colonoscopy investigation were selected. Between 2001 and 2015, 485 adults with CF attended the clinic; 70 adults with CF had an initial colonoscopy procedure. After five exclusions, standard bowel preparation was prescribed for 27 patients, and modified CF bowel preparation for 38 patients. Demographic and clinical data were collected for all consenting patients.
Results: There was a significant difference between modified CF bowel preparation group and standard bowel preparation group in bowel visualisation outcomes, with the modified CF bowel preparation group having a higher proportion of "excellent/good" GI visualisation cleanse (50.0% versus 25.9%) and lower rates of "poor" visualisation cleanse (10.5% versus 44.5%) than standard bowel preparation (p = 0.006). Rates of "fair" GI cleanse visualisation were similar between the two groups (39.4% versus 29.6%) (Additional file 1: Table S1). Detection rates of adenomatous polyps at initial colonoscopy was higher in modified CF bowel preparation cohort than with standard preparation group (50.0% versus 18.5%, p < 0.01). Positive adenomatous polyp detection rate in patient's age > 40 years of age was higher (62.5%) than those < 40 years of age (24.3%) (p = 0.003). Colonic adenocarcinoma diagnosis was similar in both groups.
Conclusion: This study primarily highlights that standard colonoscopy bowel preparation is often inadequate in patients with CF, and that colonic lavage using modified CF bowel preparation is required to obtain good colonic visualisation. A higher rate of polyps in patients over 40 years of age (versus less than 40 years) was evident. These results support adults with CF considered for colonoscopy screening at 40 years of age, or prior to this if symptomatic; which is earlier than CRC screening in the non-CF Australian population.
Keywords: Bowel preparation; Colonic cleanse; Colonic lavage; Colonoscopy; Colonoscopy screening; Colorectal cancer screening; Cystic fibrosis; Gastrointestinal visualisation; Modified cystic fibrosis bowel preparation; Polyp detection.
Conflict of interest statement
AM received TPCH private practice trust fund support to attend / present at national CF conference. AM received salaries from Griffith University and University of Sunshine Coast for delivery of Medical Nutrition Therapy sessional lectures.
DS was the Recipient of Grant Funding from Vertex Pharmaceuticals. JS and KH received TPCH private practice trust fund to finance attendance / presentation at national CF conference and funding from Vertex Pharmaceuticals to attend a Dietitian CF Interest Group Meeting. RH received Honorarium from Shire and Fresenius Kabi for expert advice and lectures. JB, AK, and SB declare that they have no competing interests.
Similar articles
-
Identifying the need for a UK colorectal cancer screening programme for patients with cystic fibrosis (CF): 10-year retrospective review of colonoscopy and colorectal cancer outcomes at a single CF centre.BMJ Open Gastroenterol. 2023 Jul;10(1):e001178. doi: 10.1136/bmjgast-2023-001178. BMJ Open Gastroenterol. 2023. PMID: 37524505 Free PMC article.
-
Case report of synchronous post-lung transplant colon cancers in the era of colorectal cancer screening recommendations in cystic fibrosis: screening "too early" before it's too late.BMC Gastroenterol. 2019 Jul 29;19(1):137. doi: 10.1186/s12876-019-1052-7. BMC Gastroenterol. 2019. PMID: 31357954 Free PMC article.
-
Cystic Fibrosis Colorectal Cancer Screening Consensus Recommendations.Gastroenterology. 2018 Feb;154(3):736-745.e14. doi: 10.1053/j.gastro.2017.12.012. Epub 2017 Dec 29. Gastroenterology. 2018. PMID: 29289528 Free PMC article.
-
Polyethylene glycol versus sodium picosulfalte bowel preparation in the setting of a colorectal cancer screening program.Can J Gastroenterol Hepatol. 2015 Oct;29(7):384-90. doi: 10.1155/2015/350587. Epub 2015 Aug 24. Can J Gastroenterol Hepatol. 2015. PMID: 26301330 Free PMC article.
-
Cancer in Cystic Fibrosis: A Narrative Review of Prevalence, Risk Factors, Screening, and Treatment Challenges: Adult Cystic Fibrosis Series.Chest. 2022 Feb;161(2):356-364. doi: 10.1016/j.chest.2021.09.003. Epub 2021 Sep 15. Chest. 2022. PMID: 34536383 Review.
Cited by
-
Identifying the need for a UK colorectal cancer screening programme for patients with cystic fibrosis (CF): 10-year retrospective review of colonoscopy and colorectal cancer outcomes at a single CF centre.BMJ Open Gastroenterol. 2023 Jul;10(1):e001178. doi: 10.1136/bmjgast-2023-001178. BMJ Open Gastroenterol. 2023. PMID: 37524505 Free PMC article.
-
A Case Report of Pulmonary Edema Secondary to Large Volume Bowel Preparation in a High-Risk Patient with Multiple Cardiopulmonary Co-Morbidities.Case Rep Gastroenterol. 2024 Mar 27;18(1):176-180. doi: 10.1159/000538158. eCollection 2024 Jan-Dec. Case Rep Gastroenterol. 2024. PMID: 38545369 Free PMC article.
-
Luminal Gastrointestinal Manifestations of Cystic Fibrosis.Curr Gastroenterol Rep. 2021 Mar 23;23(3):4. doi: 10.1007/s11894-021-00806-5. Curr Gastroenterol Rep. 2021. PMID: 33758994 Review.
References
-
- Yamada A, Komaki Y, Komaki F, Micic D, Zullow S, Sakuraba A. Risk of gastrointestinal cancers in patients with cystic fibrosis: a systematic review and meta-analysis. Lancet Oncol. 2018. 10.1016/S1470-2045(18)30188-8. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical